Impact of HLA compatibility on lung transplant survival and evidence for an HLA restriction phenomenon: A collaborative transplant study report

Transplantation

Volumn 90, Issue 8, 2010, Pages 912-917

  Opelz, Gerhard ^a   Süsal, Caner ^a   Ruhenstroth, Andrea ^a   Döhler, Bernd ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Genetic restriction; Graft survival; HLA matching; Lung transplantation

Indexed keywords

HLA A ANTIGEN; HLA B ANTIGEN; HLA DR ANTIGEN; HLA ANTIGEN;

ADOLESCENT; ADULT; ARTICLE; CADAVER DONOR; CHILD; DATA BASE; FEMALE; GRAFT FAILURE; GRAFT PRESERVATION; GRAFT SURVIVAL; HEART LUNG TRANSPLANTATION; HLA MATCHING; HUMAN; INFANT; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRESCHOOL CHILD; PRIORITY JOURNAL; RISK FACTOR; SCHOOL CHILD; SURVIVAL RATE; CLINICAL TRIAL; HISTOCOMPATIBILITY TEST; IMMUNOLOGY; METHODOLOGY; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; PHYSIOLOGY; STATISTICS; TREATMENT OUTCOME;

ADOLESCENT; ADULT; CHILD; FEMALE; GRAFT SURVIVAL; HISTOCOMPATIBILITY TESTING; HLA ANTIGENS; HLA-A ANTIGENS; HLA-B ANTIGENS; HLA-DR ANTIGENS; HUMANS; LUNG TRANSPLANTATION; MALE; MIDDLE AGED; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 78349273540     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3181f2c981     Document Type: Article

References (24)

1. Quantz MA, Bennett LE, Meyer DM, et al. Does human leukocyte antigen matching influence the outcome of lung transplantation? An analysis of 3,549 lung transplantations. J Heart Lung Transplant 2000; 19: 473.
2. Trulock EP, Edwards LB, Taylor DO, et al. Registry of the International Society for Heart and Lung Transplantation: Twenty-third official adult lung and heart-lung transplantation report-2006. J Heart Lung Transplant 2006; 25: 880.
3. Smits JMA, Mertens BJA, van Houwelingen HC, et al. Predictors of lung transplant survival in Eurotransplant. Am J Transplant 2003; 3: 1400.
4. van den Berg JWK, Hepkema BG, Geertsma A, et al. Long-term outcome of lung transplantation is predicted by the number of HLA-DR mismatches. Transplantation 2001; 71: 368.
5. Wisser W, Wekerle T, Zlabinger G, et al. Influence of human leukocyte antigen matching on long-term outcome after lung transplantation. J Heart Lung Transplant 1996; 15: 1209.
6. Sundaresan S, Mohanakumar T, Smith MA, et al. HLA-A locus mismatches and development of antibodies to HLA after lung transplantation correlate with the development of bronchiolitis obliterans syndrome. Transplantation 1998; 65: 648.
7. Kroshus TJ, Kshettry VR, Savik K, et al. Risk factors for the development of bronchiolitis obliterans syndrome after lung transplantation. J Thorac Cardiovasc Surg 1997; 114: 195.
8. Schulman LL, Weinberg AD, McGregor CC, et al. Influence of donor and recipient HLA locus mismatching on development of obliterative bronchi-olitis after lung transplantation. Am J Respir Crit Care Med 2001; 163: 437.
9. Chalermskulrat W, Neuringer IP, Schmitz JL, et al. Human leukocyte antigen mismatches predispose to the severity of bronchiolitis obliter-ans syndrome after lung transplantation. Chest 2003; 123: 1825.
10. Collaborative Transplant Study. University of Heidelberg. Available at: http://www.ctstransplant.org. Accessed April 19, 2010.
11. Wujciak T, Opelz G. A proposal for improved cadaver kidney allocation. Transplantation 1993; 56: 1513.
12. Bund M, Struber M, Heine J, et al. Effect of lung allograft ischaemia duration on postreperfusion graft function and postoperative course. Thorac Cardiovasc Surg 1998; 46: 93.
13. Opelz G, Dohler B. Effectof human leukocyte antigen compatibility on kidney graft survival: Comparative analysis of two decades. Transplantation 2007; 84: 137.
14. Opelz G, Wujciak T. The influence of HLA compatibility on graft survival after heart transplantation. The Collaborative Transplant Study. N Engl J Med 1994; 330: 816.
15. Donaldson P, Underhill J, Doherty D, et al. Influence of human leukocyte antigen matching on liver allograft survival and rejection: "The dualistic effect." Hepatology 1993; 17: 1008.
16. Markus BH, Duquesnoy RJ, Gordon RD, et al. Histocompatibility and liver transplant outcome. Does HLA exert a dualistic effect? Transplantation 1988; 46: 372.
17. Neumann UP, Guckelberger O, Langrehr JM, et al. Impact of human leukocyte antigen matching in liver transplantation. Transplantation 2003; 75: 132.
18. van der Bij W, Speich R. Management of cytomegalovirus infection and disease after solid-organ transplantation. Clin Infect Dis 2001; 33(suppl 1): S32.
19. Zinkernagel RM, Doherty PC. MHC-restricted cytotoxic T cells: Studies on the biological role of polymorphic major transplantation antigens determining T-cell restriction-specificity, function, and responsiveness. Adv Immunol 1979; 27: 51.
20. Pouteil-Noble C, Betuel H, Raffaele P, et al. Influence of HLA compatibility on cytomegalovirus infection in kidney transplantation. Presse Med 1991; 20: 2022.
21. Blancho G, Josien R, Douillard D, et al. The influence of HLA A-B-DR matching on cytomegalovirus disease after renal transplantation. Evidence that HLA-DR7-matched recipients are more susceptible to cytomegalovirus disease. Transplantation 1992; 54: 871.
22. Calmus Y, Hannoun L, Dousset B, et al. HLA class I matching is responsible for the hepatic lesions in recurrent viral hepatitis B after liver transplantation. Transplant Proc 1990; 22: 2311.
23. Remund KF, Best M, Egan JJ. Infections relevant to lung transplantation. Proc Am Thorac Soc 2009; 6: 94.
24. Sibley RK, Sutherland DE, Goetz F, et al. Recurrent diabetes mellitus in the pancreas iso- and allograft. A light and electron microscopic and immunohistochemical analysis of four cases. Lab Invest 1985; 53: 132.